Assessment of the comprehensiveness of paediatric national immunisation programmes in Europe: expert validation and future perspectives
Sign Up to like & getrecommendations! Published in 2024 at "Expert Review of Vaccines"
DOI: 10.1080/14760584.2024.2324939
Abstract: ABSTRACT Background The breadth of protection of National Immunisation Programmes (NIPs) across Europe varies, however, this has not been assessed within published literature. Therefore, a framework was developed to assess the comprehensiveness of pediatric NIPs… read more here.
Keywords: framework; comprehensiveness; national immunisation; immunisation programmes ... See more keywords
Hospital admission for symptomatic COVID‐19 and impact of vaccination: analysis of linked data from the Coronavirus Clinical Information Network and the National Immunisation Management Service
Sign Up to like & getrecommendations! Published in 2022 at "Anaesthesia"
DOI: 10.1111/anae.15677
Abstract: SARS-CoV-2 vaccines administered in the UK are highly effective in preventing hospitalisation and death from COVID-19 [1]. Patients with immunocompromise are less likely to be able to mount a satisfactory immunological response to the vaccine… read more here.
Keywords: national immunisation; dose failure; vaccination; covid ... See more keywords
Lessons to be learned: Using National Immunisation strategies to improve adherence to acute rheumatic fever secondary prophylaxis
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Paediatrics and Child Health"
DOI: 10.1111/jpc.14596
Abstract: Rheumatic heart disease, as a result of a single or recurrent episode of acute rheumatic fever (ARF), remains a significant cause of morbidity and mortality in northern and remote Australia; ARF has a peak incidence… read more here.
Keywords: national immunisation; secondary prophylaxis; acute rheumatic; rheumatic fever ... See more keywords
Seroprevalence of meningococcal serogroup C bactericidal antibodies in the Portuguese population, a decade after vaccine introduction in the National Immunisation Programme
Sign Up to like & getrecommendations! Published in 2021 at "PLoS ONE"
DOI: 10.1371/journal.pone.0250103
Abstract: Background The incidence of invasive meningococcal disease due to serogroup C (MenC) decreased in Portugal since the introduction of the conjugate vaccine (MCC) in the free market in 2001 and in the National Immunisation Plan… read more here.
Keywords: introduction; national immunisation; portuguese population; serogroup ... See more keywords